ArticleThe journal of headache and pain2023

Is the right way to go in between? : Rimegepant as needed provides preventive benefit. A comment on: monthly migraine days, tablet utilization, and quality of life associated with rimegepant-post hoc results from an open label safety study (BHV3000-201).

Andreas R Gantenbein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.